SEO-ABM

Regulatory documentation module

SEO-ABM

Stage IV

Preparation of product registration documentation


Introducing new medicinal products into clinical use requires the submission of an extensive dossier to the Office for Registration of Medicinal Products (URPL), prepared in the standardised Common Technical Document (CTD) format. The documentation includes the following modules: Quality (Module 3), Nonclinical Study Reports (Module 4) and Clinical Study Reports (Module 5). The project will include the physicochemical studies required for this documentation, while the experiments planned under Stages I and II will be described in the section devoted to pharmaceutical development studies (Module 3). Module 4 and part of Module 5 are being prepared on the basis of published literature. The results of the animal studies will be included in Module 4 of the dossier.

The quality requirements for the ingredients and the finished product must comply with the European Pharmacopoeia. This applies in particular to the active substances, namely the antibiotics. Manufacturers of medicinal products must identify antibiotic suppliers able to provide the appropriate supporting documentation. This search has already been completed under the project, and manufacturers of vancomycin hydrochloride and cefuroxime sodium holding the relevant Certificates of Suitability to the monographs of the European Pharmacopoeia (CEPs) have been identified.